- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02929368
SHERLOCK 3CG vs. Fluoroscopy in Implantation of PICC-Line (3CG)
Randomized Controlled Noninferiority Study to Evaluate Safety and Efficacy of the Integrated Magnetic Tracking and ECG-guided Tip Location System (SHERLOCK 3CG) vs. Fluoroscopy in Implantation of Peripherally Inserted Central Catheter
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Peripherally inserted central catheters, or PICC lines, are clinically used for many years in the treatment of patients, whereby the implantation occurs under x-ray/fluoroscopy. Female and male patients of legal age that have the medical indication for Power-PICC-Line catheter implantation can be screened for the study. These medical indications include the necessity of chemotherapy in the course of an oncological treatment or parenteral nutrition. The study objective is to test the efficacy and safety of the SHERLOCK system, evaluated by a monocentric, randomized-controlled study. The advantage for the participating patients lies in a reduced radiation exposure due to the discontinued final chest x-ray examination (fluoroscopy). Furthermore, the SHERLOCK system can be deployed directly on ward, at the patient's bedside leading to a cost and time saving. Recruited in- and outpatients (of legal age) with indication for Power-PICC-Line catheter implantation will be randomly assigned to one of the two arms (fluoroscopy or SHERLOCK). Depending on randomization, the Power-PICC implantation occurs either under fluoroscopy or with the SHERLOCK system. All related substances, measures or procedures are performed according to the clinical routine. The medical device is a fully integrated magnetic tracking and ECG-based peripherally inserted central catheter (PICC) tip confirmation technology applied on patients with normal sinus rhythm and placed through a peripheral vein. The Sherlock system is CE-certified since December 2011.
The referral of patients with indication to PICC-Line implantation at the institute of diagnostic and interventional radiology occurs through different departments of the University Hospital Jena. The patients are registered for radiological treatment and checked again by a radiologist if a PICC-Line implantation is indicated. If this is the case, the radiologist conducts an informed consent discussion with the patient about possible complications and risks during intervention and informs him also about a possible study. After signature of the written informed consent, the patient is included. On the intervention day, the patient is randomly assigned to one of the two study arms through RandomTool (Sherlock vs. fluoroscopy). According to randomization group, the PICC catheter is implanted (duration: 30 minutes) and eventually a chest x-ray (fluoroscopy) is performed to assess safety and efficacy.The intervention time from puncture to catheter placement is documented. After intervention, the patient is transferred back to the ward or sent home in hemodynamically stable conditions. The examination of the puncture site before discharge is performed by a ward physician or by the family doctor. 24 h after PICC-Line implantation, the treating physician is contacted and questioned about possible complications (catheter occlusion, haematoma, infection of the puncture site, arm vein thrombosis, pain, etc.), that are then thoroughly documented.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Thuringia
-
Jena, Thuringia, Germany, 07747
- University Hospital Jena
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- female, male
- adults ≥ 18 years
- medical indication for Power-PICC-Line catheter implantation because of chemotherapy or parenertal nutrition
- in- and outpatients
Exclusion Criteria:
- children and adolescents < 18 years
- systemic or local infection of the interventional location
- known allergy to used material
- general contraindication of Power-PICC-Line catheter implantation
- nonexistent sinus rhythm (5)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Fluoroscopy
PICC Implantation under x-ray
|
PICC Catheter implantation
|
Active Comparator: Sherlock System (BARD)
PICC Implantation with Integrated Magnetic Tracking and ECG-guided Tip Location System
|
PICC Catheter implantation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Tip Placement efficiency measured by chest radiograph
Time Frame: through study completion, an average of 2 years
|
Corect placement through anatomic evaluation of chest x-ray measuring catheter tip max.
two vertebral bodies under carina
|
through study completion, an average of 2 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Safety measured by follow-up interview with referring physician and documentation of AE
Time Frame: Follow-up within one week
|
Documentation of periprocedural complications
|
Follow-up within one week
|
Implantation time
Time Frame: intraoperative
|
time during PICC implantation
|
intraoperative
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Heike Habrecht, Dr. med., University Hospital Jena, Germany
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 4567/10/15
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Patients With PICC-Line
-
Second Affiliated Hospital, School of Medicine,...Sir Run Run Shaw Hospital; Zhejiang Provincial People's HospitalActive, not recruitingCancer Patients With PICCChina
-
Universitaire Ziekenhuizen KU LeuvenCompletedPatients With Any Condition Who Need a PICC for IV TherapyBelgium
-
National Cancer Center, KoreaCompletedPatients Cannulated With Both PICC and CICC. | The Rapidly Fluctuating Hemodynamics During LT.Korea, Republic of
-
Milton S. Hershey Medical CenterCompletedCentral Venous Catheter | Central Line | PICC | Neuro ICU | Neuroscience ICU | CVCUnited States
-
University Hospital, BrestUnknown
-
Angiodynamics, Inc.TerminatedPatients Indicated for a PICC for Any Medical ConditionSwitzerland, United States, Canada
-
Centre Hospitalier Saint Joseph Saint Luc de LyonNot yet recruitingIV Line Placement With UltrasoundFrance
-
Medtronic - MITGCompletedSubjects With an Existing Intra-arterial LineUnited States
-
University Hospital, Clermont-FerrandGroupe Hospitalier Pitie-SalpetriereCompletedAdult Patients Ventilated More Than 48 h | Stable Respiratory and Hemodynamic Conditions for SBT | Consent of Patients | Arterial LineFrance
-
University Hospital, Clermont-FerrandUnknownConsent of Patients | Arterial Line | Adult Patients | Tracheal Intubation in ICUFrance
Clinical Trials on PICC implantation under fluoroscopy
-
YiYang ZhuCompleted
-
Complejo Hospitalario Universitario de GranadaUnknownFacet Joint Pain | Facet Syndrome of Lumbar Spine | Facet Joints; DegenerationSpain
-
NDR Medical Technology Pte LtdUniversity of MalayaCompleted
-
Diskapi Teaching and Research HospitalCompletedBack Pain | Sacroiliac Joint ArthritisTurkey
-
Pusan National University HospitalCompleted
-
Cutting Edge SAStargomedGmbHRecruitingCataract | Lens OpacitiesSpain, Czechia
-
Cutting Edge SAStargomedGmbHRecruitingCataract | Lens OpacitiesSingapore, Spain, Czechia, Germany, Philippines, Austria
-
Brigham and Women's HospitalSiemens Medical Solutions USA - CSGCompletedLung CancerUnited States
-
Peking University Third HospitalCompleted
-
Johns Hopkins UniversityCompleted